ANNA FOWLER: Open Payments
NPI 1942924881 · CONCORD, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,035 in 97 payments from 21 companies in 2025. Trend: 2023 $1,576 · 2024 $1,742 · 2025 $2,035
Food & beverage: $2,035
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $401 |
| Janssen Biotech, Inc. | 11 | $369 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $227 |
| Gilead Sciences, Inc. | 9 | $157 |
| Aimmune Therapeutics, Inc. | 5 | $135 |
| Phathom Pharmaceuticals, Inc. | 5 | $102 |
| Regeneron Healthcare Solutions, Inc. | 4 | $99 |
| PFIZER INC. | 4 | $81 |
| Alnylam Pharmaceuticals Inc. | 4 | $75 |
| Madrigal Pharmaceuticals | 3 | $65 |
Products named: TREMFYA, ENTYVIO, RINVOQ, ZENPEP, DUPIXENT, LINZESS, VOQUEZNA, XELJANZ.
Industry payments across NC — which companies pay providers there.
